GLP-1 (Glucagon-Like Peptide-1) medications are a class of drugs initially developed to treat type 2 diabetes
Semaglutide works by activating GLP-1 receptors in the brain and pancreas, slowing gastric emptying and reducing hunger signals
This article belongs to the PlexusDx Education Hub, our library on GLP-1 medicine, weight-management protocols, and the genetics underneath both
The combination regimens of TPM+VPA, LEV+VPA, and TPM+LEV+VPA exhibited an increased risk relative to treatment with VPA alone, as indicated by ROR values of 2.06, 1.37, and 1.74, respectively
How Semaglutide Works The main function of semaglutide is imitating hormones, specifically the GLP-1 hormone that gets released after eating and regulates satiety